Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

6 treatments under study, led by Double Umbilical Cord Blood Unit Transplant

Research Leaders

5 sponsors active, led by Blood and Marrow Transplant Clinical Trials Network

Related Conditions

Often studied with 4 related conditions

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 5/100

Termination Rate

0.0%

0 terminated out of 1 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

100%

1 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

1Total
Phase 3 (1)

Trial Status

Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (1)

Showing 1 of 1 trials
NCT00412360Phase 3Completed

Single vs Double Umbilical Cord Blood Transplants in Children With High Risk Leukemia and Myelodysplasia (BMT CTN 0501)

Showing all 1 trials

Research Network

Common Treatments

  • Double Umbilical Cord Blood Unit Transplant1
  • Mycophenolate Mofetil1
  • Single Umbilical Cord Blood Unit Transplant1
  • Cyclosporine1
  • Cyclophosphamide1

Active Sponsors

  • Blood and Marrow Transplant Clinical Trials Network1
  • National Marrow Donor Program1
  • National Cancer Institute (NCI)1
  • Medical College of Wisconsin1
  • National Heart, Lung, and Blood Institute (NHLBI)1

Top Investigators

Related Conditions

  • Acute Lymphocytic Leukemia1
  • Myelodysplastic Syndrome1
  • Acute Myelogenous Leukemia1
  • Chronic Myelogenous Leukemia1

Activity Timeline